The present invention relates to tricyclic pyrazoles according to Formula
(I) that are useful for treating cellular proliferative diseases, for
treating disorders associated with KSP kinesin activity, and for
inhibiting KSP kinesin. The invention also relates to compositions which
comprise these compounds, and methods of using them to treat cancer in
mammals. ##STR00001##